Rubens⚡️

10.4K posts

Rubens⚡️ banner
Rubens⚡️

Rubens⚡️

@IsRubens

Hematologist & transplant physician | Interested in CAR-T therapies

Guadalajara, Jalisco Beigetreten Şubat 2011
691 Folgt499 Follower
Rubens⚡️
Rubens⚡️@IsRubens·
Haploidentical SCT in AML: higher GVHD & NRM, but lower relapse → no significant difference in LFS. Donor choice is more nuanced than ever. #Hematology #BMT #AML #EBMT
Rubens⚡️ tweet media
English
0
1
8
350
Rubens⚡️
Rubens⚡️@IsRubens·
High-risk MDS: outcomes after allo-SCT still strongly shaped by biology. TP53 mutations (especially biallelic) and higher pre-SCT blasts markedly worsen OS. Better risk stratification → better decisions. #MDS #Hematology #BMT #TP53
Rubens⚡️ tweet media
English
0
3
1
129
Rubens⚡️ retweetet
María Marta Rivas
María Marta Rivas@MariMRivas·
At EBMT 2026 in Madrid, a powerful message has resonated across sessions: Donors matter! HLA disparity is no longer a barrier—it’s becoming a tool for patients whose only curative option remains hematopoietic stem cell transplantation. #EBMT2026 #DonorsMatter #HSCT #HLA
María Marta Rivas tweet mediaMaría Marta Rivas tweet mediaMaría Marta Rivas tweet media
English
0
6
16
960
Rubens⚡️
Rubens⚡️@IsRubens·
From learning to presenting, an oral at @TheEBMT alongside the CAR-T & transplant team. Grateful to the team and to share it with Mexican colleagues and friends. #EBMT @valerotmo
Rubens⚡️ tweet mediaRubens⚡️ tweet mediaRubens⚡️ tweet media
English
0
2
6
506
Andres Gomez
Andres Gomez@GomezDLeonMD·
Transplant is very hard to implement in LMICs. We have done it through hard work, creativity, clinical research and institutional support. Fact accredited, now working hard to implement #CARTcells. The @TheEBMT made a video about our transplant program. Watch it here: youtube.com/watch?v=_OVxFY…
YouTube video
YouTube
English
5
8
39
2.5K
Rubens⚡️
Rubens⚡️@IsRubens·
At #EBMT26, one key takeaway: TP53-ddPCR + flow refine MRD beyond standards. Clearing clones pre-HSCT is critical in AML—post-HSCT targeting may reshape relapse.
Rubens⚡️ tweet mediaRubens⚡️ tweet mediaRubens⚡️ tweet media
English
0
1
12
853
Aldesleukin
Aldesleukin@RaulAldesleukin·
La reuma me anda haciendo ojitos
Español
1
0
1
53
Rubens⚡️
Rubens⚡️@IsRubens·
Industry drives innovation. Academia must drive purpose. CAR-T development is not only about pushing boundaries, but about ensuring equitable, high-quality, and accessible care. That’s the real endpoint. #EBMT26 #CellTherapy @hospitalclinic @hematoclinicbcn 🙌🏼🔝
Rubens⚡️ tweet mediaRubens⚡️ tweet mediaRubens⚡️ tweet media
English
0
1
5
331
Rubens⚡️
Rubens⚡️@IsRubens·
Honored to see my mentor and friend, Dr. @valerotmo, at #EBMT2026 leading by example—pushing his transplant team and residents to grow, excel, and redefine what’s possible in our field. Inspiring the next generation, one step ahead. #Hematology #Transplant #CART
Andrés Bonilla@linfoblastosabs

Today - present 2 printed póster - EBMT 2026 ✅Early Ruxolitinib use in lung GVHD ✅Outcomes of Post-Transplant Patients Admitted to the ICU #EBMT26 #EBMTPOSTER #Younghematology @ContactoAmeh

English
0
1
7
558
Rubens⚡️
Rubens⚡️@IsRubens·
Indeed
Cristobal Frutos@chano_py

#EBMT26 Plenary Session on Multiple Myeloma Thats the slide Hopefully in the future we may stop offering HCT to patients It is very hard to endure for most patients Not yet though

English
0
0
1
157
Rubens⚡️
Rubens⚡️@IsRubens·
Is Aza+Ven really better than 7+3 in AML? Strong responses and tolerability, but no clear OS benefit and key biases. Molecular risk may refine who benefits. Debate ongoing. #AML #EBMT26 Excellent talk by dr. Gesine Bug 🇩🇪
Rubens⚡️ tweet mediaRubens⚡️ tweet mediaRubens⚡️ tweet mediaRubens⚡️ tweet media
English
0
5
36
1.7K
Rubens⚡️
Rubens⚡️@IsRubens·
Great to see @QueraltSalas at the acute leukemias workshop at @TheEBMT , presenting her work on frailty and prehabilitation in allo. Inspiring work in this field. #ebmt26
Rubens⚡️ tweet media
English
0
9
24
895
FJGR
FJGR@fcojavier_gr·
Important work highlighting what we see every day: not all patients tolerate therapy the same way. Assessing frailty before starting treatment in Hematology helps shape decisions from the start. Congrats to Dr. Solís Armenta on this great contribution! 🩸 #CART #EBMT2026
Rubens⚡️@IsRubens

Honored to present our work on frailty in CAR-T. Grateful to @QueraltSalas for pioneering this field and to the Clínic CAR-T team. #CART #Hematology #EBMT2026

English
1
3
6
737